Background illustration for clinical trials search

Paid Clinical Trials Daytona Beach

Discover 861 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 861

A Pilot Study of RISE for Nurse Managers Retreat

for

Burnout, Secondary Traumatic Stress, Perceived Stress

Location: Orlando FL

Sponsor: AdventHealth

Sex: All

Age: 18+

Code: NCT07298018

Recruiting

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

for

Adenoma Colon Polyp

Location: Orlando FL

Sponsor: AdventHealth

Sex: All

Age: 18+

Code: NCT06476145

Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for

Glioblastoma

Location: Orlando FL, Atlanta GA, Greenville NC, Fairfax VA,

Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

for

Colorectal Cancer

Location: Orlando FL, Jacksonville FL, Salem VA, Norfolk VA,

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT06948448

Phase2, Recruiting

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

for

Breast Cancer, Lung Cancer (Diagnosis), Prostate Cancer

Location: Orlando FL

Sponsor: AdventHealth

Sex: All

Age: 18+

Code: NCT07231159

Recruiting

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for

Atrial Fibrillation (AF), Persistant Atrial Fibrillation,

Location: Orlando FL, Jacksonville FL, Charleston SC, Atlanta GA,

Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

for

Advanced-stage Solid Tumors

Location: Orlando FL, Irving TX

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07223125

Phase1, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for

Prostate Cancer

Location: Orlando FL, Fort Myers FL, Miami FL, Charleston SC,

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,

Location: Orlando FL, Gainesville FL, Jacksonville FL,

Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

for

Respiratory Distress Syndrome, Pre-term Infants

Location: Orlando FL, Jacksonville FL, Charlottesville VA,

Sponsor: Aerogen Pharma Limited

Sex: All

Age: 0

Code: NCT06776783

Phase3, Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

for

Pulmonary Hypertension, Interstitial Lung Disease

Location: Orlando FL, Tampa FL, Charleston SC, Indianapolis IN,

Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06129240

Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,

Location: Orlando FL, Gainesville FL, Tampa FL, Clearwater FL,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase3, Recruiting

Closed Loop and Education for Hypoglycemia Awareness Restoration

for

Diabetes Mellitus, Type 1

Location: Orlando FL, Lexington KY, Philadelphia PA,

Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06325202

Recruiting

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for

Colitis Ulcerative, Ulcerative Colitis

Location: Orlando FL, Inverness FL, Miami FL, Macon GA,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07463183

Phase2, Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for

Non-small Cell Lung Cancer (NSCLC)

Location: Orlando FL, New Orleans LA, Fairfax VA,

Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for

Prostate Cancer

Location: Orlando FL, Miami FL, Myrtle Beach SC, Athens GA,

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for

Somatostatin Receptor Positive (SSTR+),

Location: Orlando FL, Jacksonville FL, Atlanta GA, Wytheville VA,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia

Location: Orlando FL, Gainesville FL, Jacksonville FL, Tampa FL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

for

Epithelial Ovarian Cancer, Ovarian Cancer,

Location: Orlando FL, Chattanooga TN, New Orleans LA, St Louis MO,

Sponsor: Imunon

Sex: Female

Age: 18+

Code: NCT06915025

Phase3, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for

B Acute Lymphoblastic Leukemia

Location: Orlando FL, Gainesville FL, Jacksonville FL, Tampa FL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

Paid Clinical Trials Daytona Beach

Filter results

A Pilot Study of RISE for Nurse Managers Retreat

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Interested in new trials?

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Closed Loop and Education for Hypoglycemia Awareness Restoration

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)